|
ERMP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.292400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.700200E-01 |
| Normal-vs-Stage2 |
1.758190E-01 |
| Normal-vs-Stage3 |
8.990300E-02 |
| Normal-vs-Stage4 |
7.404100E-02 |
| Stage1-vs-Stage2 |
7.619600E-02 |
| Stage1-vs-Stage3 |
1.402970E-01 |
| Stage1-vs-Stage4 |
1.441020E-01 |
| Stage2-vs-Stage3 |
1.495510E-02 |
| Stage2-vs-Stage4 |
1.244230E-02 |
| Stage3-vs-Stage4 |
7.599800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.225400E-01 |
| Normal-vs-AfricanAmerican |
6.322400E-01 |
| Normal-vs-Asian |
5.917600E-01 |
| Caucasian-vs-AfricanAmerican |
9.008600E-01 |
| Caucasian-vs-Asian |
8.311000E-01 |
| AfricanAmerican-vs-Asian |
9.776000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.384600E-01 |
| Normal-vs-Female |
4.365200E-01 |
| Male-vs-Female |
9.605000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.161200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.225020E-01 |
| Normal-vs-Age(61-80Yrs) |
4.008000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.009700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.115770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.267400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.694200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.946440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.953570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.918000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.341750E-02 |
| Classical-VS-Follicular |
3.182400E-03 |
| Classical-VS-Other |
8.797600E-01 |
| Classical-VS-Normal |
2.476600E-01 |
| Tall-VS-Follicular |
3.63290000000571E-05 |
| Tall-VS-Other |
1.845960E-01 |
| Tall-VS-Normal |
5.700300E-03 |
| Follicular-VS-Other |
4.103200E-01 |
| Follicular-VS-Normal |
7.649900E-02 |
| Other-VS-Normal |
7.763600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.696600E-01 |
| Normal-vs-N1 |
1.180210E-02 |
| N0-vs-N1 |
1.056440E-02 |
|
|
